LigaChem Biosciences Inc. (KOSDAQ: 141080)
South Korea
· Delayed Price · Currency is KRW 93,500
-2,900 (-3.01%)
Dec 20, 2024, 9:00 AM KST
LigaChem Biosciences Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | 2017 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2014 |
| Revenue | 101,417 | 34,146 | 33,412 | 32,157 | 57,500 | 25,240 | Upgrade
|
| Revenue Growth (YoY) | 194.22% | 2.20% | 3.90% | -44.07% | 127.81% | 14.43% | Upgrade
|
| Cost of Revenue | 15,838 | 16,348 | 15,563 | 14,459 | 22,689 | 19,332 | Upgrade
|
| Gross Profit | 85,579 | 17,797 | 17,849 | 17,698 | 34,811 | 5,908 | Upgrade
|
| Selling, General & Admin | 17,420 | 12,226 | 5,628 | 4,829 | 6,032 | 4,797 | Upgrade
|
| Research & Development | 98,611 | 79,609 | 51,110 | 39,071 | 16,711 | 15,505 | Upgrade
|
| Operating Expenses | 117,983 | 98,620 | 68,224 | 45,404 | 26,394 | 21,886 | Upgrade
|
| Operating Income | -32,404 | -80,822 | -50,375 | -27,707 | 8,417 | -15,978 | Upgrade
|
| Interest Expense | -580.58 | -528.26 | -285.75 | -68.77 | -25.8 | -125.75 | Upgrade
|
| Interest & Investment Income | 15,482 | 5,808 | 4,267 | 901.31 | 1,542 | 425.05 | Upgrade
|
| Earnings From Equity Investments | 1,282 | 838.1 | 52.28 | 120.25 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 1,547 | 1,218 | 2,601 | 1,841 | -586.08 | 6.99 | Upgrade
|
| Other Non Operating Income (Expenses) | 8,561 | 4,815 | -1,655 | 4,081 | -233.69 | 34.4 | Upgrade
|
| EBT Excluding Unusual Items | -6,114 | -68,672 | -45,396 | -20,832 | 9,113 | -15,637 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,982 | -6,853 | -2,088 | 486.48 | 3,989 | 668.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | 10.4 | 37.83 | 1.13 | -177.86 | -0.41 | 7 | Upgrade
|
| Asset Writedown | -260.19 | -260.19 | -301.66 | - | - | -11,465 | Upgrade
|
| Other Unusual Items | - | - | 61.98 | - | - | - | Upgrade
|
| Pretax Income | -4,382 | -75,747 | -47,723 | -20,523 | 13,102 | -26,427 | Upgrade
|
| Income Tax Expense | -1,449 | -2,043 | -2,631 | 2,868 | 626.01 | -354.09 | Upgrade
|
| Earnings From Continuing Operations | -2,932 | -73,704 | -45,092 | -23,391 | 12,476 | -26,073 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 1,111 | 302.26 | Upgrade
|
| Net Income | -2,932 | -73,704 | -45,092 | -23,391 | 13,586 | -25,770 | Upgrade
|
| Net Income to Common | -2,932 | -73,704 | -45,092 | -23,391 | 13,586 | -25,770 | Upgrade
|
| Shares Outstanding (Basic) | 34 | 28 | 28 | 24 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 28 | 28 | 24 | 24 | 21 | Upgrade
|
| Shares Change (YoY) | 14.62% | 1.38% | 16.13% | 0.47% | 13.94% | 5.92% | Upgrade
|
| EPS (Basic) | -86.38 | -2594.83 | -1609.47 | -969.59 | 640.57 | -1222.79 | Upgrade
|
| EPS (Diluted) | -86.38 | -2595.00 | -1609.47 | -970.00 | 566.00 | -1222.79 | Upgrade
|
| Free Cash Flow | 44,563 | -63,555 | -11,300 | -60,358 | 20,743 | -16,515 | Upgrade
|
| Free Cash Flow Per Share | 1312.64 | -2237.54 | -403.33 | -2501.88 | 863.87 | -783.62 | Upgrade
|
| Gross Margin | 84.38% | 52.12% | 53.42% | 55.03% | 60.54% | 23.41% | Upgrade
|
| Operating Margin | -31.95% | -236.70% | -150.77% | -86.16% | 14.64% | -63.30% | Upgrade
|
| Profit Margin | -2.89% | -215.85% | -134.96% | -72.74% | 23.63% | -102.10% | Upgrade
|
| Free Cash Flow Margin | 43.94% | -186.13% | -33.82% | -187.70% | 36.07% | -65.43% | Upgrade
|
| EBITDA | -27,458 | -76,150 | -46,257 | -24,658 | 12,282 | -13,198 | Upgrade
|
| EBITDA Margin | -27.07% | -223.02% | -138.44% | -76.68% | 21.36% | -52.29% | Upgrade
|
| D&A For EBITDA | 4,947 | 4,672 | 4,118 | 3,049 | 3,865 | 2,780 | Upgrade
|
| EBIT | -32,404 | -80,822 | -50,375 | -27,707 | 8,417 | -15,978 | Upgrade
|
| EBIT Margin | -31.95% | -236.70% | -150.77% | -86.16% | 14.64% | -63.30% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 4.78% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.